Compliance with Testosterone Replacement Therapy in Patients with Testosterone Deficiency Syndrome: A 10-Year Observational Study in Korea

다국어 초록 (Multilingual Abstract)

Purpose: To determine the compliance rate with testosterone replacement therapy (TRT) in patients with testosterone deficiency syndrome (TDS), we evaluated the treatment continuation rate and the reasons for discontinuation of initial treatment according to each formulations and patient characteristics.
Materials and Methods: Among men over 40 years of age who were diagnosed with TDS and then underwent TRT, their medical records were retrospectively analyzed for those who were followed up for more than 10 years.
Results: A total of 640 patients were included in the analysis. It was found that 75.9% of patients continued treatment for 1 year after starting. Patients treated with 1,000 mg of testosterone undecanoate injection had the highest treatment rate. Inconvenience of medication was the most common reason for discontinuing treatment, followed by cost, concern about side effects, lack of efficacy, and symptom recovery. The reasons for discontinuing treatment differed according to the type of formulations, and the longest continuous treatment period in all patients was 15.4±7.6 months on average. The treatment continuation rate tended to be high in patients with low serum total testosterone before starting treatment, in patients with severe erectile dysfunction, and in patients using phosphodiesterase-5 (PDE5) inhibitors.
Conclusions: Among the various formulations of TDS, testosterone undecanoate injection (1,000 mg) had the highest compliance rate. In addition, it was found that the reasons for discontinuation of treatment varied according to the characteristics of each formulation.

참고문헌 (Reference)

1 Moon DG, "The efficacy and safety of testosterone undecanoate(Nebido(®))in testosterone deficiency syndrome in Korean : a multicenter prospective study" 7 : 2253-2260, 2010

2 Bassil N, "The benefits and risks of testosterone replacement therapy : a review" 5 : 427-448, 2009

3 Bhasin S, "Testosterone therapy in men with hypogonadism : an Endocrine Society clinical practice guideline" 103 : 1715-1744, 2018

4 Buvat J, "Testosterone deficiency in men : systematic review and standard operating procedures for diagnosis and treatment" 10 : 245-284, 2013

5 Giovanni Corona ; Alessandra Sforza ; Mario Maggi, "Testosterone Replacement Therapy: Long-Term Safety and Efficacy" 대한남성과학회 35 (35): 65-76, 2017

6 Parsons JK, "Serum testosterone and the risk of prostate cancer : potential implications for testosterone therapy" 14 : 2257-2260, 2005

7 Al-Shaiji TF, "Phosphodiesterase type 5 inhibitors for the management of erectile dysfunction : preference and adherence to treatment" 15 : 3486-3495, 2009

8 Pastuszak AW, "Pharmacokinetic evaluation and dosing of subcutaneous testosterone pellets" 33 : 927-937, 2012

9 Park HJ, "Evolution of guidelines for testosterone replacement therapy" 8 : 410-, 2019

10 Mulhall JP, "Evaluation and management of testosterone deficiency : AUA guideline" 200 : 423-432, 2018

11 이동섭 ; 박현준, "Efficacy and Safety of Testosterone Therapy Based on Guideline Recommendations; Re: Clinical Practice Guideline by the American College of Physicians" 대한남성과학회 38 (38): 397-401, 2020

12 Park HJ, "Discontinuation of dapoxetine treatment in patients with premature ejaculation : a 2-year prospective observational study" 5 : e99-105, 2017

13 Khera M, "Diagnosis and treatment of testosterone deficiency : recommendations from the fourth International Consultation for Sexual Medicine(ICSM 2015)" 13 : 1787-1804, 2016

14 Gooren LJ, "Androgen replacement therapy : present and future" 64 : 1861-1891, 2004

15 Zirkin BR, "Aging and declining testosterone : past, present, and hopes for the future" 33 : 1111-1118, 2012

16 Calof OM, "Adverse events associated with testosterone replacement in middle-aged and older men : a meta-analysis of randomized, placebo-controlled trials" 60 : 1451-1457, 2005

17 Isidori AM, "A critical analysis of the role of testosterone in erectile function : from pathophysiology to treatment-a systematic review" 65 : 99-112, 2014